Rosemary (Rosmarinus officinalis L.) extract inhibits prostate cancer cell proliferation and survival by targeting Akt and mTOR

Biomedicine & Pharmacotherapy

Deborah Termini¹  Evangelia Tsiani¹  Alina Jaglanian¹ 

[1] Department of Health Sciences, Brock University, St. Catharines, ON, L2S 3A1, Canada;

关键词: Rosemary extract;    Prostate cancer;    Proliferation;    Survival;    Akt;    mTOR;   

DOI  :  

来源: DOAJ

【 摘 要 】

Prostate cancer is the most commonly diagnosed type of cancer in North American men and is typically classified as either androgen receptor positive or negative depending on the expression of the androgen receptor (AR). AR positive prostate cancer can be treated with hormone therapy while AR negative prostate cancer is aggressive and does not respond to hormone therapy. It has been previously reported that rosemary extract (RE) has antioxidant, anti-inflammatory and anti-cancer properties. In the present study, we found that treatment of the androgen-insensitive PC-3 prostate cancer cells with RE resulted in a significant inhibition of proliferation, survival, migration, Akt, and mTOR signaling. In addition, treatment of the androgen-sensitive 22RV1 prostate cancer cells with RE resulted in a significant inhibition of proliferation and survival while RE had no effect on normal prostate epithelial PNT1A cells. These findings suggest that RE has potent effects against prostate cancer and warrants further investigation.

【 授权许可】

Unknown